Currently, studies on different targets of MM are also being carried out, including G protein‐coupled receptor, class C Group 5 member D (GPRC5D), Fc receptor‐homolog 5 (FcRH5), CD38, and CD138 [3]. Here, GPRC5D is linked to Miyoshi myopathy.